Carol Suh

Carol Suh

Oprichter bij
Orbital Therapeutics, Inc.
35 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Carol Suh was the founder of Neumora Therapeutics, Inc., founded in 2019, where the title held was Chief Strategy Officer from 2025 to 2026.
Ms. Suh is the founder of Orbital Therapeutics, Inc., founded in 2022, holding the title of Director since 2022.
Current jobs include Director at Metrodora SL since 2021, Director at Human Immunology Biosciences, Inc. since 2021, and Partner at ARCH Venture Partners LLC since 2018.
Former jobs include Director at HIBio, Inc., Consultant at Trinity Partners LLC from 2015 to 2016, and Associate-Business Development & Strategy at Magenta Therapeutics, Inc. in 2017.
Education history includes undergraduate studies at Harvard University, graduate studies at Yale University, and an MBA from Stanford Graduate School of Business.

Actieve functies van Carol Suh

BedrijvenFunctieBegin
Private Equity Investor 01-07-2021
Directeur/Bestuurslid 01-08-2021
Oprichter 01-03-2022
Directeur/Bestuurslid 01-10-2021

Eerdere bekende functies van Carol Suh

BedrijvenFunctieEinde
NEUMORA THERAPEUTICS, INC. Oprichter 01-02-2026
MAGENTA THERAPEUTICS Corporate Officer/Principal 01-09-2017
Consultant / Adviseur 01-05-2016
Directeur/Bestuurslid -
Ervaring van Carol Suh in detail bekijken

Opleiding van Carol Suh

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

66

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Finance

Consumer Services

Consumer Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Carol Suh